CN109439690A - A kind of two-way solid fermentation process of monascus-Chinese medicine - Google Patents

A kind of two-way solid fermentation process of monascus-Chinese medicine Download PDF

Info

Publication number
CN109439690A
CN109439690A CN201811357192.6A CN201811357192A CN109439690A CN 109439690 A CN109439690 A CN 109439690A CN 201811357192 A CN201811357192 A CN 201811357192A CN 109439690 A CN109439690 A CN 109439690A
Authority
CN
China
Prior art keywords
monascus
chinese medicine
fermentation process
way solid
solid fermentation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201811357192.6A
Other languages
Chinese (zh)
Inventor
张安育
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hefei Huagai Biotechnology Co Ltd
Original Assignee
Hefei Huagai Biotechnology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hefei Huagai Biotechnology Co Ltd filed Critical Hefei Huagai Biotechnology Co Ltd
Priority to CN201811357192.6A priority Critical patent/CN109439690A/en
Publication of CN109439690A publication Critical patent/CN109439690A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/02Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Botany (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention belongs to Chinese traditional medicine biology technical fields, and in particular to a kind of two-way solid fermentation process of monascus-Chinese medicine.It comprises the steps of: (1) crushing the Chinese medicine of mass ratio 1:(1-3) and rice by pulverizer, then 20 meshes are crossed, again plus distilled water mixes after impregnating and obtains fermentation substrate, fermentation substrate is fitted into the culture bottle of 250mL, 2 hours of sterilizing at 115-120 DEG C are put into high-pressure sterilizing pot;(2) it is inoculated into above-mentioned culture bottle after monascus being expanded culture processing, seals, culture bottle is placed in be protected from light in ventilated environment and is fermented;(3) tunning, 60 DEG C of drying are collected after fermentation time.The two-way solid fermentation process of monascus-Chinese medicine of the invention can improve active ingredients from traditional Chinese medicinal content, convert the new active constituent of generation, mitigate toxic side effect, have important social effect and economic value.

Description

A kind of two-way solid fermentation process of monascus-Chinese medicine
Technical field
The invention belongs to Chinese traditional medicine biology technical fields, and in particular to a kind of two-way solid fermentation process of monascus-Chinese medicine.
Background technique
Monascus is China's traditional zymotic product --- the production strain of red yeast rice, monascus are inoculated in rice medium through sending out Product after ferment is red yeast rice, has the applicating history of more than one thousand years in China, be mainly used for food color, preservative and in Medicine compatibility.Bioconversion is that the various enzymes proposed using microorganism or from microorganism make substrate carry out certain as biocatalyst Kind chemical reaction.
Chinese medicine active constituent is usually because content is low, resource is limited, structure is complicated, is unable to the disadvantages of chemical synthesis and difficult To develop into new drug.Microorganism especially fungi has the ability of very strong decomposition and inversion substance, and can generate abundant secondary Metabolite, therefore, with it is general either physically or chemically compared with, pharmacological property can be significantly changed using microorganism conversion Chinese herbal medicine, Curative effect is improved, toxic side effect is reduced, expands indication.Professors Zhuan Yi etc. create " two-way solid fermentation " first and try out, Medicinal fungi is seeded in Chinese medicine matrix, carries out solid fermentation under given conditions, generation has effects that new component, new Medicinal fungal substance, since " pharmacological property matrix " can not only provide nutrition needed for fungi, while the enzyme of fungi also can decompose Chinese medicine or The structural constituent of Chinese medicine slag to generate new ingredient and effect, therefore claims " bi-directional fermentation ", and it is novel that here it is medicinal fungis (amphicheirality) solid fermentation, abbreviation bi-directional fermentation.The Chinese invention patent of Publication No. CN103908489A discloses a seed ginseng Chinese medicine ginseng, Radix Astragali are crushed mixed preparing fermentation substrate by the two-way solid fermentation method of stilbene sesame medicinal fungal substance, this method;It will growth And be stored in the lucidum strain in PDA culture medium and be respectively connected to ferment in culture bottle, obtained ginseng stilbene sesame medicinal fungal substance is anti-oxidant Activity is higher than former Chinese medicine.The Chinese invention patent of Publication No. CN105176844A discloses a kind of Chinese medicine of Inonotus obliquus Or Inonotus obliquus is seeded on Chinese medicine or Chinese medicine slag pharmacological property matrix and carries out by the two-way solid fermentation method of Chinese medicine slag, this method The medicinal fungal substance of two-way solid fermentation, production is non-toxic, and there is good antioxidation, blood sugar reducing function and immunological regulation etc. to make With.
Monascus can generate a variety of different enzymes in breeding, and certain ingredients of Chinese medicine are under the action of these enzymes Biochemical reaction occurs, generates new active constituent.There is no literature reported on the two-way solid fermentation process of the Chinese medicine of monascus at present And its pharmacotoxicological effect of medicinal fungal substance.
Summary of the invention
In view of the deficiencies of the prior art, the purpose of the present invention is to provide a kind of two-way solid fermentations of monascus-Chinese medicine Technique can improve active ingredients from traditional Chinese medicinal content, conversion generates new active constituent, mitigates toxic side effect.
To achieve the above object, the present invention adopts the following technical scheme:
The present invention provides a kind of two-way solid fermentation process of monascus-Chinese medicine, comprise the steps of:
(1) Chinese medicine of mass ratio 1:(1-3) and rice are crushed by pulverizer, then cross 20 meshes, then plus distilled water it is mixed Fermentation substrate is obtained after even immersion, fermentation substrate is fitted into the culture bottle of 250mL, is put into high-pressure sterilizing pot in 115-120 It sterilizes at DEG C 2 hours;
(2) it is inoculated into above-mentioned culture bottle after monascus being expanded culture processing, seals, culture bottle is placed in and is protected from light ventilated environment Middle fermentation;
(3) tunning, 60 DEG C of drying are collected after fermentation time.
Radix Salviae Miltiorrhizae is a kind of Chinese medicine that potential applicability in clinical practice is very wide, and step (1) described Chinese medicine is life in 2 years Red sage root.
Since excessive Chinese medicine can inhibit the growth of monascus, the mass ratio of step (1) Chinese medicine and rice is excellent It is more appropriate to be selected as 1:1.
When water content is lower, the phase is relatively dry after fermentation for matrix, can inhibit the speed of growth of monascus, therefore step (1) The water content of the fermentation substrate is preferably within the scope of 110%-120%.
Preferably, the pH value of step (1) described fermentation substrate is 5.
The charge of matrix has larger impact for fermentation results, and confluent cultures bottom of bottle layer is unable to when matrix amount is less, Monascus slow growth causes active component content lower, when matrix is excessive, although the growth of monascus incipient stage is rapidly, But since the bed of material is thicker, it is difficult after fermentation the bed of material is long thoroughly, active component content is caused to receive influence, therefore step (1) The quality of the fermentation substrate is preferably 18-22g.
Preferably, step (2) monascus expands culture processing method particularly includes: 250mL cone is added in 50g rice In shape bottle, sterilize at 121 DEG C 30min after impregnating 30min with tap water;Test tube slant monascus specie one is taken, use is sterile Sour water washes down monascus ruber spore, then with aseptic straw inoculating spores suspension 2.5mL, cultivates 6 days in 32 DEG C of incubators, will Monascus ruber spore on the grain of rice, which is washed down, is made spore suspension.
Mycelium is less when inoculum concentration is very little, is not easy to cover with matrix, and mycelium is excessive, and mycoplasma stickiness increases, and monascus exists Although early growth is rapid in matrix, there is aging in the later period, slow growth, and since fermentation process can generate heat, when The very fast heat of rate of rise in temperature is not easy to remove when mycelium is excessive, and the inoculum concentration of step (2) described inoculation is preferably 35%- 42%。
Preferably, step (2) environment temperature for being protected from light ventilated environment controls within the scope of 27-29 DEG C.
Preferably, step (3) fermentation time is 23-25 days.
The invention has the following beneficial effects:
Monascus is seeded in greatly by the two-way solid fermentation process of monascus-Chinese medicine of the invention using two-way solid-fermented technique On the composite interstitial substance of rice and Chinese medicine composition, while Fermentation Condition of Monascus spp aerial mycelium and metabolite, the enzyme of generation can be urged The chemical component for changing Chinese medicine converts, and improves active ingredients from traditional Chinese medicinal content, conversion generates new active constituent, mitigates poison Side effect.The present invention has determined that optimal Chinese medicine and rice quality ratio are 1:1 by a large number of experiments, and best fermentation substrate contains Water is 110%-120%, and the quality of best fermentation substrate is 18-22g, optimum inoculation amount 35%-42%, optimal yeasting Temperature is 27-29 DEG C, and optimum fermentation time is 23-25 days, and under the above conditions, the active component content of Chinese medicine can be with Reach maximum value.
Specific embodiment
Present invention will be further explained below with reference to specific examples.These embodiments are merely to illustrate the present invention and do not have to In limiting the scope of the invention.
Embodiment 1
A kind of two-way solid fermentation process of monascus-Chinese medicine is present embodiments provided, is comprised the steps of:
(1) 2 years of mass ratio 1:3 raw red sage roots and rice are crushed by pulverizer, then cross 20 meshes, then plus distilled water it is mixed Fermentation substrate is obtained after even immersion, fermentation substrate is fitted into the culture bottle of 250mL, is put into high-pressure sterilizing pot at 115 DEG C It sterilizes 2 hours;
(2) it is inoculated into above-mentioned culture bottle after monascus being expanded culture processing, seals, culture bottle is placed in and is protected from light ventilated environment Middle fermentation;
(3) tunning, 60 DEG C of drying are collected after fermenting 23 days.
The water content of step (1) described fermentation substrate is 110% in the present embodiment.
The pH value of step (1) described fermentation substrate is 5 in the present embodiment.
The quality of step (1) described fermentation substrate is 18g in the present embodiment.
Step (2) monascus expands culture processing in the present embodiment method particularly includes: 50g rice is added In 250mL conical flask, sterilize at 121 DEG C 30min after impregnating 30min with tap water;Test tube slant monascus specie one is taken, Monascus ruber spore is washed down with sterile sour water, then with aseptic straw inoculating spores suspension 2.5mL, is cultivated in 32 DEG C of incubators 6 days, the monascus ruber spore on the grain of rice is washed down, spore suspension is made.
The inoculum concentration of step (2) described inoculation is 35% in the present embodiment.
Step (2) environment temperature for being protected from light ventilated environment is controlled at 27 DEG C in the present embodiment.
Embodiment 2
A kind of two-way solid fermentation process of monascus-Chinese medicine is present embodiments provided, is comprised the steps of:
(1) 2 years of mass ratio 1:2 raw red sage roots and rice are crushed by pulverizer, then cross 20 meshes, then plus distilled water it is mixed Fermentation substrate is obtained after even immersion, fermentation substrate is fitted into the culture bottle of 250mL, is put into high-pressure sterilizing pot at 118 DEG C It sterilizes 2 hours;
(2) it is inoculated into above-mentioned culture bottle after monascus being expanded culture processing, seals, culture bottle is placed in and is protected from light ventilated environment Middle fermentation;
(3) tunning, 60 DEG C of drying are collected after fermenting 25 days.
The water content of step (1) described fermentation substrate is 115% in the present embodiment.
The pH value of step (1) described fermentation substrate is 5 in the present embodiment.
The quality of step (1) described fermentation substrate is 22g in the present embodiment.
Step (2) monascus expands culture processing in the present embodiment method particularly includes: 50g rice is added In 250mL conical flask, sterilize at 121 DEG C 30min after impregnating 30min with tap water;Test tube slant monascus specie one is taken, Monascus ruber spore is washed down with sterile sour water, then with aseptic straw inoculating spores suspension 2.5mL, is cultivated in 32 DEG C of incubators 6 days, the monascus ruber spore on the grain of rice is washed down, spore suspension is made.
The inoculum concentration of step (2) described inoculation is 42% in the present embodiment.
Step (2) environment temperature for being protected from light ventilated environment is controlled at 29 DEG C in the present embodiment.
Embodiment 3
A kind of two-way solid fermentation process of monascus-Chinese medicine is present embodiments provided, is comprised the steps of:
(1) 2 years of mass ratio 1:1 raw red sage roots and rice are crushed by pulverizer, then cross 20 meshes, then plus distilled water it is mixed Fermentation substrate is obtained after even immersion, fermentation substrate is fitted into the culture bottle of 250mL, is put into high-pressure sterilizing pot at 120 DEG C It sterilizes 2 hours;
(2) it is inoculated into above-mentioned culture bottle after monascus being expanded culture processing, seals, culture bottle is placed in and is protected from light ventilated environment Middle fermentation;
(3) tunning, 60 DEG C of drying are collected after fermenting 24 days.
The water content of step (1) described fermentation substrate is 120% in the present embodiment.
The pH value of step (1) described fermentation substrate is 5 in the present embodiment.
The quality of step (1) described fermentation substrate is 20g in the present embodiment.
Step (2) monascus expands culture processing in the present embodiment method particularly includes: 50g rice is added In 250mL conical flask, sterilize at 121 DEG C 30min after impregnating 30min with tap water;Test tube slant monascus specie one is taken, Monascus ruber spore is washed down with sterile sour water, then with aseptic straw inoculating spores suspension 2.5mL, is cultivated in 32 DEG C of incubators 6 days, the monascus ruber spore on the grain of rice is washed down, spore suspension is made.
The inoculum concentration of step (2) described inoculation is 40% in the present embodiment.
Step (2) environment temperature for being protected from light ventilated environment is controlled at 28 DEG C in the present embodiment.
Using Mo Nakelin K and tanshinone IIA content as index, the fermentation of measurement embodiment 1, embodiment 2 and embodiment 3 is produced The measuring method of the content of active constituent in object, Mo Nakelin K content is as follows: taking 2g monascus-Radix Salviae Miltiorrhizae product by solid-state fermentation molten In 40mL water, 2h, filtering, filter residue drying are centrifuged in 150rpm;Add 40mL petroleum ether, ultrasonic 1h sloughs pigment, centrifugation, in abandoning Clearly, precipitating drying;Add 75% ethyl alcohol 30mL, 50 DEG C ultrasound 2 times, each 50min, filtering, merging filtrate, 75% ethyl alcohol is settled to 60mL;300 μ L filtrates are drawn, the dilution of 75% ethyl alcohol is settled to 10mL, obtains sample solution.Using dual-wavelength ultraviolet spectrophotometry Absorbance (A) of the sample solution at 247nm and 253nm is measured, calculating difference A247-A253 finds out sample according to standard curve The concentration of Mo Nakelin K in product solution, further calculates out the content of Mo Nakelin K in sample.The measurement of tanshinone IIA content With the following method: take 2g monascus-Radix Salviae Miltiorrhizae product by solid-state fermentation to be dissolved in 10 times of volumes methanols, 50 DEG C ultrasonic extraction 2 times, Each 40min, merging filtrate are settled to 20mL.1mL filtrate is taken to cross 0.22 μm of filter membrane, using high performance liquid chromatograph sample introduction point Analysis, according to the content of calculated by peak area target substance out.Acquired results are as shown in table 1 below:
Table 1
Test item Mo Nakelin K content (mg/g) Tanshinone IIA content (mg/g)
Embodiment 1 1.31 0.98
Embodiment 2 1.45 1.19
Embodiment 3 1.71 1.33
As can be seen from the above table, the content of Mo Nakelin K and the content of tanshinone IIA in embodiment 1, embodiment 2 and embodiment 3 Higher level is reached, wherein the Mo Nakelin K content of embodiment 3 and tanshinone IIA content are significantly higher than embodiment 1 and reality Example 2 is applied, illustrates that the technological condition for fermentation of embodiment 3 is the optimal selection of the present invention.
Specific embodiments of the present invention are described above.It is to be appreciated that the invention is not limited to above-mentioned Particular implementation, those skilled in the art can make various deformations or amendments within the scope of the claims, this not shadow Ring substantive content of the invention.

Claims (10)

1. a kind of two-way solid fermentation process of monascus-Chinese medicine, which is characterized in that comprise the steps of:
(1) Chinese medicine of mass ratio 1:(1-3) and rice are crushed by pulverizer, then cross 20 meshes, then plus distilled water it is mixed Fermentation substrate is obtained after even immersion, fermentation substrate is fitted into the culture bottle of 250mL, is put into high-pressure sterilizing pot in 115-120 It sterilizes at DEG C 2 hours;
(2) it is inoculated into above-mentioned culture bottle after monascus being expanded culture processing, seals, culture bottle is placed in and is protected from light ventilated environment Middle fermentation;
(3) tunning, 60 DEG C of drying are collected after fermentation time.
2. a kind of two-way solid fermentation process of monascus-Chinese medicine according to claim 1, it is characterised in that: step (1) The Chinese medicine is 2 years raw red sage roots.
3. a kind of two-way solid fermentation process of monascus-Chinese medicine according to claim 1, it is characterised in that: step (1) The mass ratio of the Chinese medicine and rice is 1:1.
4. a kind of two-way solid fermentation process of monascus-Chinese medicine according to claim 1, it is characterised in that: step (1) The water content of the fermentation substrate controls within the scope of 110%-120%.
5. a kind of two-way solid fermentation process of monascus-Chinese medicine according to claim 1, it is characterised in that: step (1) The pH value of the fermentation substrate is 5.
6. a kind of two-way solid fermentation process of monascus-Chinese medicine according to claim 1, it is characterised in that: step (1) The quality of the fermentation substrate is 18-22g.
7. a kind of two-way solid fermentation process of monascus-Chinese medicine according to claim 1, which is characterized in that step (2) The monascus expands culture processing method particularly includes: 50g rice is added in 250mL conical flask, is impregnated with tap water Sterilize at 121 DEG C 30min after 30min;Test tube slant monascus specie one is taken, is washed monascus ruber spore with sterile sour water Under, then with aseptic straw inoculating spores suspension 2.5mL, cultivated 6 days in 32 DEG C of incubators, by the monascus ruber spore on the grain of rice It washes down and spore suspension is made.
8. a kind of two-way solid fermentation process of monascus-Chinese medicine according to claim 1, it is characterised in that: step (2) The inoculum concentration of the inoculation is 35%-42%.
9. a kind of two-way solid fermentation process of monascus-Chinese medicine according to claim 1, it is characterised in that: step (2) The environment temperature for being protected from light ventilated environment controls within the scope of 27-29 DEG C.
10. a kind of two-way solid fermentation process of monascus-Chinese medicine according to claim 1, it is characterised in that: step (3) fermentation time is 23-25 days.
CN201811357192.6A 2018-11-15 2018-11-15 A kind of two-way solid fermentation process of monascus-Chinese medicine Withdrawn CN109439690A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811357192.6A CN109439690A (en) 2018-11-15 2018-11-15 A kind of two-way solid fermentation process of monascus-Chinese medicine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811357192.6A CN109439690A (en) 2018-11-15 2018-11-15 A kind of two-way solid fermentation process of monascus-Chinese medicine

Publications (1)

Publication Number Publication Date
CN109439690A true CN109439690A (en) 2019-03-08

Family

ID=65553465

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811357192.6A Withdrawn CN109439690A (en) 2018-11-15 2018-11-15 A kind of two-way solid fermentation process of monascus-Chinese medicine

Country Status (1)

Country Link
CN (1) CN109439690A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111840397A (en) * 2020-08-24 2020-10-30 广州三广生物科技有限公司 Firming and bacteriostatic enzyme liquid and preparation method thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111840397A (en) * 2020-08-24 2020-10-30 广州三广生物科技有限公司 Firming and bacteriostatic enzyme liquid and preparation method thereof

Similar Documents

Publication Publication Date Title
CN109266562A (en) One plant height produces ethyl acetate exception Brunswick Durham yeast and its cultural method and application
CN102676392B (en) Endophytic fungus in salvia miltiorrhiza bunge and application thereof
CN102217487B (en) Method for producing mycelia of Antrodia camphorata through deep liquid state fermentation
CN102559828B (en) Method for preparing astragaloside IV by converting total saponins of astragalus by microorganisms
CN108384701A (en) A kind of preparation method of the fermented type fruit vinegar rich in anthocyanin
CN110684672B (en) Fermentation method of antioxidant cordyceps sobolifera mycelium
CN104357332A (en) Aspergillus niger JH-2 and application to biotransformation and synthesis of asiatic acid
CN118028383A (en) Method for promoting synthesis of Cannabidiol (CBD) of filamentous fungi by using plant elicitors
CN109439690A (en) A kind of two-way solid fermentation process of monascus-Chinese medicine
CN105580638A (en) Method for promoting antrodia camphorata liquid state fermentation growth and triterpene synthesis
CN103981104A (en) Endophytic fungus and method for biologically converting glycyrrhizic acid into glycyrrhetinic glycoside by using same
CN106883010A (en) Antrodia growth promoter and the method with its quick fermentation production antrodia
CN102643754B (en) Aspergillus oryzae and application thereof in aspect of improving yield of alcohol
CN110024623A (en) L-PROLINE is improving the application in aweto blastopore quantity and hypha biomass
CN113502230B (en) Hericium erinaceus strain and culture method thereof, hericium erinaceus-ginseng bidirectional solid fermentation method and method for efficiently converting rare ginsenoside
CN116179407A (en) Enterococcus faecium and application thereof in bio-conversion of secoisolariciresinol diglucoside
CN109022501A (en) A method of ferulic acid is obtained using waste
CN104673681A (en) Inonotus obliquus QD04 and method for converting polygonum cuspidatum by same to produce resveratrol, triterpenoid saponin and polysaccharide
CN110699263B (en) Aspergillus niger YH-6 and application thereof in improving content of icaritin in epimedium
CN103865804B (en) Beta-glucosidase Producing Strain and the application in resveratrol is prepared in conversion thereof
CN108948036A (en) A kind of cochliobolus quinone B derivative and its production bacterial strain and application
CN110305918A (en) A kind of method of Antrodia camphorata fermentation coupling extraction production 4-Acetylantroquinonol B
CN103614322B (en) The streptomycete producing Glycosylase and the application prepared in bio-transformation in Cucurbitacin B thereof
CN104894172A (en) Method for producing resveratrol by microbial transformation and Brussels Dekkera mutant strain
JP6478366B2 (en) Alcohol production method

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication
WW01 Invention patent application withdrawn after publication

Application publication date: 20190308